DOI QR코드

DOI QR Code

Quercetin Enhances Cisplatin Sensitivity of Human Osteosarcoma Cells by Modulating microRNA-217-KRAS Axis

  • Zhang, Xian (Department of Orthopaedics, the First Hospital Affiliated of Henan University) ;
  • Guo, Qinggong (Department of Orthopaedics, the First Hospital Affiliated of Henan University) ;
  • Chen, Jingtao (Department of Orthopaedics, the First Hospital Affiliated of Henan University) ;
  • Chen, Zhaohui (Department of Orthopaedics, the First Hospital Affiliated of Henan University)
  • Received : 2015.02.10
  • Accepted : 2015.04.23
  • Published : 2015.07.31

Abstract

Quercetin can suppress osteosarcoma cell growth and metastasis. However, other effects of quercetin on osteosarcoma remain largely unknown. This research aims to evaluate the effects of quercetin in combination with cisplatin as treatment for osteosarcoma and investigate its regulatory mechanism. Cell viability and apoptosis in 143B cell line were determined after treatment with quercetin and/or cisplatin. RT-PCR and Western blot analysis were performed to determine the RNA or protein expression levels. Moreover, transwell assay was used to evaluate metastasis. Furthermore, rescue experiments were performed to investigate the potential regulatory mechanism of the treatment. Results showed that quercetin with concentration that was equal to or greater than $10{\mu}M$ inhibited 143B proliferation, while $5{\mu}M$ quercetin enhanced the cisplatin sensitivity of 143B cells. Expression of miR-217 was upregulated after quercetin and/or cisplatin treatment, while its target KRAS was downregulated both at mRNA and protein levels. MiR-217 knockdown led to the loss of enhanced cisplatin sensitivity while miR-217 overexpression showed the opposite effects, indicating that quercetin regulated cisplatin sensitivity by modulating the miR-217-KRAS axis. In conclusion, $5{\mu}M$ quercetin enhanced the cisplatin sensitivity by modulating the miR-217-KRAS axis. This finding suggests that quercetin may be administered with cisplatin to improve the treatment for osteosarcoma.

Acknowledgement

Supported by : National Natural Science Foundation of China

References

  1. Berndt, K., Campanile, C., Muff, R., Strehler, E., Born, W., and Fuchs, B. (2013). Evaluation of quercetin as a potential drug in osteosarcoma treatment. Anticancer Res. 33, 1297-1306.
  2. Bielack, S.S., Carrle, D., Hardes, J., Schuck, A., and Paulussen, M. (2008). Bone tumors in adolescents and young adults. Curr. Treat Options Oncol. 9, 67-80. https://doi.org/10.1007/s11864-008-0057-1
  3. Chou, A.J., Gupta, R., Bell, M.D., Riewe, K.O., Meyers, P.A., and Gorlick, R. (2013). Inhaled lipid cisplatin (ILC) in the treatment of patients with relapsed/progressive osteosarcoma metastatic to the lung. Pediatr. Blood Cancer 60, 580-586. https://doi.org/10.1002/pbc.24438
  4. Galluzzi, L., Senovilla, L., Vitale, I., Michels, J., Martins, I., Kepp, O., Castedo, M., and Kroemer, G. (2012). Molecular mechanisms of cisplatin resistance. Oncogene 31, 1869-1883. https://doi.org/10.1038/onc.2011.384
  5. Guo, J.H., Feng, Z.J., Huang, Z., Wang, H.Y., and Lu, W.J. (2014). MicroRNA-217 functions as a tumour suppressor gene and correlates with cell resistance to cisplatin in lung cancer. Mol. Cells 37, 664-671. https://doi.org/10.14348/molcells.2014.0121
  6. Kato, M., Putta, S., Wang, M., Yuan, H., Lanting, L., Nair, I., Gunn, A., Nakagawa, Y., Shimano, H., Todorov, I., et al. (2009). TGFbeta activates Akt kinase through a microRNA-dependent amplifying circuit targeting PTEN. Nat. Cell Biol. 11, 881-U263. https://doi.org/10.1038/ncb1897
  7. Kim, J.Y., Kim, E.H., Park, S.S., Lim, J.H., Kwon, T.K., and Choi, K.S. (2008). Quercetin sensitizes human hepatoma cells to TRAIL-induced apoptosis via Sp1-mediated DR5 upregulation and proteasome-mediated c-FLIPS down-regulation. J. Cell Biochem. 105, 1386-1398. https://doi.org/10.1002/jcb.21958
  8. Li, N., Sun, C., Zhou, B., Xing, H., Ma, D., Chen, G., and Weng, D. (2014). Low concentration of quercetin antagonizes the cytotoxic effects of anti-neoplastic drugs in ovarian cancer. PLoS One 9, e100314. https://doi.org/10.1371/journal.pone.0100314
  9. Liang, W., Li, X., Li, C., Liao, L., Gao, B., Gan, H., Yang, Z., and Chen, X. (2011). Quercetin-mediated apoptosis via activation of the mitochondrial-dependent pathway in MG-63 osteosarcoma cells. Mol. Med. Rep. 4, 1017-1023.
  10. Martinez-Velez, N., Xipell, E., Jauregui, P., Zalacain, M., Marrodan, L., Zandueta, C., Vera, B., Urquiza, L., Sierrasesumaga, L., Julian, M.S., et al. (2014). The oncolytic adenovirus Delta24-RGD in combination with cisplatin exerts a potent antiosteosarcoma activity. J. Bone Miner Res. 29, 2287-2296. https://doi.org/10.1002/jbmr.2253
  11. Orsolic, N., and Car, N. (2014). Quercetin and hyperthermia modulate cisplatin-induced DNA damage in tumor and normal tissues in vivo. Tumour. Biol. 35, 6445-6454. https://doi.org/10.1007/s13277-014-1843-y
  12. Scambia, G., Ranelletti, F.O., Benedetti Panici, P., Bonanno, G., De Vincenzo, R., Piantelli, M., and Mancuso, S. (1990). Synergistic antiproliferative activity of quercetin and cisplatin on ovarian cancer cell growth. Anticancer Drugs 1, 45-48. https://doi.org/10.1097/00001813-199010000-00008
  13. Shen, D.W., Pouliot, L.M., Hall, M.D., and Gottesman, M.M. (2012). Cisplatin resistance: a cellular self-defense mechanism resulting from multiple epigenetic and genetic changes. Pharmacol. Rev. 64, 706-721. https://doi.org/10.1124/pr.111.005637
  14. SS, B. (2012). A review of quercetin: Antioxidant and anticancer properties. World J. Pharm. Pharm. Sci. 1, 146-160.
  15. Suh, D.K., Lee, E.J., Kim, H.C., and Kim, J.H. (2010). Induction of G(1)/S phase arrest and apoptosis by quercetin in human osteosarcoma cells. Arch. Pharm. Res. 33, 781-785. https://doi.org/10.1007/s12272-010-0519-4
  16. Wang, P., Vadgama, J.V., Said, J.W., Magyar, C.E., Doan, N., Heber, D., and Henning, S.M. (2014). Enhanced inhibition of prostate cancer xenograft tumor growth by combining quercetin and green tea. J. Nutr. Biochem. 25, 73-80. https://doi.org/10.1016/j.jnutbio.2013.09.005
  17. Wu, J., Liao, Q., He, H., Zhong, D., and Yin, K. (2014). TWIST interacts with beta-catenin signaling on osteosarcoma cell survival against cisplatin. Mol. Carcinog. 53, 440-446. https://doi.org/10.1002/mc.21991
  18. Xie, X.B., Yin, J.Q., Jia, Q., Wang, J., Zou, C.Y., Brewer, K.J., Colombo, C., Wang, Y.F., Huang, G., and Shen, J.N. (2011). Quercetin induces apoptosis in the methotrexate-resistant osteosarcoma cell line U2-OS/MTX300 via mitochondrial dysfunction and dephosphorylation of Akt. Oncol. Rep. 26, 687-693.
  19. Yi, L., Zongyuan, Y., Cheng, G., Lingyun, Z., Guilian, Y., and Wei, G. (2014). Quercetin enhances apoptotic effect of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) in ovarian cancer cells through reactive oxygen species (ROS) mediated CCAAT enhancer-binding protein homologous protein (CHOP)-death receptor 5 pathway. Cancer Sci. 105, 520-527. https://doi.org/10.1111/cas.12395
  20. Zhao, W.G., Yu, S.N., Lu, Z.H., Ma, Y.H., Gu, Y.M., and Chen, J. (2010). The miR-217 microRNA functions as a potential tumor suppressor in pancreatic ductal adenocarcinoma by targeting KRAS. Carcinogenesis 31, 1726-1733. https://doi.org/10.1093/carcin/bgq160
  21. Zhao, G.Y., Cai, C.K., Yang, T.T., Qiu, X.C., Liao, B., Li, W., Ji, Z.W., Zhao, J., Zhao, H.E., Guo, M.J., et al. (2013). MicroRNA-221 induces cell survival and cisplatin resistance through PI3K/Akt pathway in human osteosarcoma. PLoS One 8, e53906. https://doi.org/10.1371/journal.pone.0053906

Cited by

  1. Quercetin suppresses the metastatic ability of lung cancer through inhibiting Snail-dependent Akt activation and Snail-independent ADAM9 expression pathways vol.1864, pp.10, 2017, https://doi.org/10.1016/j.bbamcr.2017.06.017
  2. Potential therapeutic implications of miRNAs in osteosarcoma chemotherapy vol.39, pp.9, 2017, https://doi.org/10.1177/1010428317705762
  3. An Fc-Small Molecule Conjugate for Targeted Inhibition of the Adenosine 2A Receptor vol.17, pp.20, 2016, https://doi.org/10.1002/cbic.201600337
  4. Activation and conformational dynamics of a class B G-protein-coupled glucagon receptor vol.18, pp.18, 2016, https://doi.org/10.1039/C6CP00798H
  5. Molecular mechanisms of action of quercetin in cancer: recent advances vol.37, pp.10, 2016, https://doi.org/10.1007/s13277-016-5184-x
  6. MicroRNAs and Potential Targets in Osteosarcoma: Review vol.3, 2015, https://doi.org/10.3389/fped.2015.00069
  7. Structural complexes of the agonist, inverse agonist and antagonist bound C5a receptor: insights into pharmacology and signaling vol.12, pp.5, 2016, https://doi.org/10.1039/C6MB00031B
  8. Phase-plate cryo-EM structure of a class B GPCR–G-protein complex vol.546, pp.7656, 2017, https://doi.org/10.1038/nature22327
  9. Flavonoid allosteric modulation of mutated visual rhodopsin associated with retinitis pigmentosa vol.7, pp.1, 2017, https://doi.org/10.1038/s41598-017-11391-x
  10. Formyl peptide receptor polymorphisms: 27 most possible ways for phagocyte dysfunction vol.82, pp.4, 2017, https://doi.org/10.1134/S0006297917040034
  11. Dietary phytochemicals as epigenetic modifiers in cancer: Promise and challenges vol.40-41, 2016, https://doi.org/10.1016/j.semcancer.2016.04.002
  12. Regulation of microRNA using promising dietary phytochemicals: Possible preventive and treatment option of malignant mesothelioma vol.94, 2017, https://doi.org/10.1016/j.biopha.2017.07.075
  13. Structure and dynamics of GPCR signaling complexes vol.25, pp.1, 2018, https://doi.org/10.1038/s41594-017-0011-7
  14. GPCR-specific autoantibody signatures are associated with physiological and pathological immune homeostasis vol.9, pp.1, 2018, https://doi.org/10.1038/s41467-018-07598-9
  15. Quercetin-mediated regulation of signal transduction cascades and microRNAs: Natural weapon against cancer vol.119, pp.12, 2018, https://doi.org/10.1002/jcb.27488
  16. PAC1 Receptors: Shapeshifters in Motion pp.1559-1166, 2018, https://doi.org/10.1007/s12031-018-1132-0
  17. Anticancer potential of quercetin: A comprehensive review pp.0951418X, 2018, https://doi.org/10.1002/ptr.6155
  18. Myricetin treatment induces apoptosis in canine osteosarcoma cells by inducing DNA fragmentation, disrupting redox homeostasis, and mediating loss of mitochondrial membrane potential vol.233, pp.9, 2018, https://doi.org/10.1002/jcp.26598
  19. Disturbance in biosynthesis of arachidonic acid impairs the sexual development of the onion blight pathogen Stemphylium eturmiunum pp.1432-0983, 2019, https://doi.org/10.1007/s00294-019-00930-w
  20. Drug resistance‐related microRNAs in osteosarcoma: Translating basic evidence into therapeutic strategies pp.1582-4934, 2019, https://doi.org/10.1111/jcmm.14064